BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 25008826)

  • 1. Clinical and microbiological characteristics of Rhodotorula mucilaginosa infections in a tertiary-care facility.
    Capoor MR; Aggarwal S; Raghvan C; Gupta DK; Jain AK; Chaudhary R
    Indian J Med Microbiol; 2014; 32(3):304-9. PubMed ID: 25008826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of Rhodotorula mucilaginosa from blood cultures in a tertiary care hospital.
    Falces-Romero I; Cendejas-Bueno E; Romero-Gómez MP; García-Rodríguez J
    Mycoses; 2018 Jan; 61(1):35-39. PubMed ID: 28922488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rhodotorula spp. isolated from blood cultures: clinical and microbiological aspects.
    De Almeida GM; Costa SF; Melhem M; Motta AL; Szeszs MW; Miyashita F; Pierrotti LC; Rossi F; Burattini MN
    Med Mycol; 2008 Sep; 46(6):547-56. PubMed ID: 19180725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rhodotorula fungemia: two cases and a brief review.
    Duggal S; Jain H; Tyagi A; Sharma A; Chugh TD
    Med Mycol; 2011 Nov; 49(8):879-82. PubMed ID: 21595509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular identification, antifungal susceptibility profile, and biofilm formation of clinical and environmental Rhodotorula species isolates.
    Nunes JM; Bizerra FC; Ferreira RC; Colombo AL
    Antimicrob Agents Chemother; 2013 Jan; 57(1):382-9. PubMed ID: 23114761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central venous catheter-associated fungemia due to Rhodotorula spp. --a systematic review.
    Tuon FF; de Almeida GM; Costa SF
    Med Mycol; 2007 Aug; 45(5):441-7. PubMed ID: 17654271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five-year evaluation of bloodstream yeast infections in a tertiary hospital: the predominance of non-C. albicans Candida species.
    Pereira GH; Müller PR; Szeszs MW; Levin AS; Melhem MS
    Med Mycol; 2010 Sep; 48(6):839-42. PubMed ID: 20163281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rhodotorula fungemia of an intensive care unit patient and review of published cases.
    Spiliopoulou A; Anastassiou ED; Christofidou M
    Mycopathologia; 2012 Oct; 174(4):301-9. PubMed ID: 22576941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A Rare Yeast: Cases of Rhodotorula mucilaginosa Infection Followed Up in a Tertiary University Hospital].
    Ayaz ÇM; Gülmez D; Arıkan Akdağlı S; Uzun Ö
    Mikrobiyol Bul; 2021 Jan; 55(1):91-98. PubMed ID: 33590984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro antifungal activities of amphotericin B, 5-fluorocytosine, fluconazole and itraconazole against Cryptococcus neoformans isolated from cerebrospinal fluid and blood from patients in Serbia.
    Trpković A; Pekmezović M; Barać A; Crnčević Radović L; Arsić Arsenijević V
    J Mycol Med; 2012 Sep; 22(3):243-8. PubMed ID: 23518082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catheter-related bloodstream infection due to Rhodotorula mucilaginosa with normal serum (1→3)-β-D-glucan level.
    Kitazawa T; Ishigaki S; Seo K; Yoshino Y; Ota Y
    J Mycol Med; 2018 Jun; 28(2):393-395. PubMed ID: 29661607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug susceptibility of 64 strains of Rhodotorula sp.
    Krzyściak P; Macura AB
    Wiad Parazytol; 2010; 56(2):167-70. PubMed ID: 20707302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology and outcome of Rhodotorula fungemia in a tertiary care hospital.
    Lunardi LW; Aquino VR; Zimerman RA; Goldani LZ
    Clin Infect Dis; 2006 Sep; 43(6):e60-3. PubMed ID: 16912936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fungemia caused by Rhodotorula mucilaginosa in relation to total parenteral nutrition].
    Jiménez-Mejías ME; Ortiz Leyba C; Jiménez Gonzalo FJ; del Nozal M; Campos T; Jiménez Jiménez FJ
    Enferm Infecc Microbiol Clin; 1992 Nov; 10(9):543-6. PubMed ID: 1489796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility profile of 29 clinical isolates of Rhodotorula spp. and literature review.
    Gomez-Lopez A; Mellado E; Rodriguez-Tudela JL; Cuenca-Estrella M
    J Antimicrob Chemother; 2005 Mar; 55(3):312-6. PubMed ID: 15695538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhodotorula mucilaginosa Fungemia and Pleural Tuberculosis in an Immunocompetent Patient: An Uncommon Association.
    Pereira C; Ribeiro S; Lopes V; Mendonça T
    Mycopathologia; 2016 Feb; 181(1-2):145-9. PubMed ID: 26369644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fungemia due to Rhodotorula mucilaginosa in an immunocompetent, critically ill patient.
    Monterrubio Villar J; González Velasco C; Jiménez Delgado JD
    Kansenshogaku Zasshi; 2013 Sep; 87(5 Suppl 8):10-2. PubMed ID: 24475695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fungemia due to Rhodotorula mucilaginosa after allogeneic hematopoietic stem cell transplantation.
    Mori T; Nakamura Y; Kato J; Sugita K; Murata M; Kamei K; Okamoto S
    Transpl Infect Dis; 2012 Feb; 14(1):91-4. PubMed ID: 21535337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rhodotorula mucilaginosa catheter-related fungaemia in a patient with multiple myeloma.
    García-Suárez J; Gómez-Herruz P; Cuadros JA; Guillén H; Burgaleta C
    Mycoses; 2011 Jul; 54(4):e214-6. PubMed ID: 20041994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low sensitivity of conventional fungal agars in fungemia by Rhodotorula mucilaginosa: description of two cases.
    Garcia-Gutiérrez CA; Cuétara-García MS; Moragues MD; Ligero J; Quevedo SM; Buitrago MJ
    Ann Clin Microbiol Antimicrob; 2021 Mar; 20(1):21. PubMed ID: 33773588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.